Fundraising FoxInbiomotion
4 known investors
Find your way into Inbiomotion
Sign up to find every way you can get introduced to Inbiomotion
- Your email: who you already know at Inbiomotion, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inbiomotion team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
Founders & leadership
Board
Investors · 4
How we know: Asabys Partners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · press coverage · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
Frequently asked questions
- What does Inbiomotion do?
- InBioMotion offers a biomarker test that analyzes MAF gene levels to assess prognosis and guide personalized bisphosphonate treatment in early breast cancer patients. The test helps oncologists reduce relapse risk and improve survival outcomes through precision medicine approaches.
- Who are Inbiomotion's investors?
- Inbiomotion's investors include Asabys Partners, Criteria Bio Ventures, Ysios Capital, Alta Life Sciences.